AB0220 What Proportion of Patients Fail To Achieve CDAI and SDAI Remission Based on Physician Global Assessment? An Analysis from A Prospective, Observational Registry

医学 Golimumab公司 类风湿性关节炎 银屑病性关节炎 英夫利昔单抗 内科学 观察研究 物理疗法 接收机工作特性 强直性脊柱炎 前瞻性队列研究 疾病 阿达木单抗
作者
Michelle C. Starr,B. Haraoui,D. Choquette,Louis Bessette,Andrew Chow,P. Baer,S. Kapur,J. Kelsall,Michelle Teo,Emmanouil Rampakakis,Eliofotisti Psaradellis,F. Nantel,A.J. Lehman,B. Osborne,K. Maslova,C.M. Tkaczyk
出处
期刊:Annals of the Rheumatic Diseases [BMJ]
卷期号:75 (Suppl 2): 973.2-973
标识
DOI:10.1136/annrheumdis-2016-eular.4801
摘要

Background

Physician9s Global Assessment of Disease Activity (MDGA) is a measure that is frequently incorporated in disease activity indices which reflects the physician9s perception of disease activity in rheumatoid arthritis (RA).

Objectives

The aim of this analysis was to assess the proportion of patients failing to achieve CDAI and SDAI remission based on MDGA in a real-world, routine clinical care setting in Canada.

Methods

BioTRAC is an ongoing, prospective registry of patients initiating treatment for RA, ankylosing spondylitis (AS), or psoriatic arthritis (PsA) with infliximab (IFX) or golimumab (GLM). Eligible patients for this analysis included RA patients treated with IFX or GLM between 2005 and 2015. Modified versions of CDAI (mCDAI) and SDAI (mSDAI) were calculated by omitting MDGA from the formulas. Correlation of the standard and modified versions of each index was assessed with the Pearson9s correlation coefficient. ROC curve analysis was used to identify new thresholds for the modified versions of low disease activity (LDA) and remission. Cross-tabulations with the Chi-square test were used to assess the agreement between the standard and modified definitions of remission and LDA.

Results

A total of 1206 patients were included in the analysis with a mean (SD) age of 56.1 (13.4) years and a disease duration of 8.4 (8.9) years. A strong positive correlation was observed between the standard and modified versions of CDAI (r=0.99; P<0.001) and SDAI (r=0.99; P<0.001). Based on ROC analysis the new thresholds for remission and LDA were: CDAI (remission=2.65, LDA=10.05) and SDAI (remission=3.31, LDA=10.73). The proportion of patients achieving remission by both indices was 17.8% and 19.5%, patients not achieving remission by both indices was 75.3% and 74.4%, and patients achieving remission by the new thresholds only was 6.9% and 6.1%, for CDAI and SDAI, respectively. Cross-tabulation of the standard and modified thresholds showed that an additional 8.4% and 7.6% of non-remission cases for CDAI and SDAI, respectively, would be classified as remission with the modified definitions. Similarly, an additional 17.6% and 15.1% of non-LDA cases for CDAI and SDAI, respectively, would be classified as LDA.

Conclusions

The results of this analysis showed that MDGA could account for up to 8% of non-remission cases and up to 18% of non-LDA cases as measured by CDAI and SDAI. Omission of MDGA from these disease activity indices could have a significant impact on patient management in preventing overtreatment with DMARDs and biologics and avoiding unnecessary switching of DMARDs and biologics.

Disclosure of Interest

M. Starr: None declared, B. Haraoui: None declared, D. Choquette: None declared, L. Bessette: None declared, A. Chow: None declared, P. Baer: None declared, S. Kapur: None declared, J. Kelsall: None declared, M. Teo: None declared, E. Rampakakis Employee of: JSS, E. Psaradellis Employee of: JSS, F. Nantel Employee of: Janssen, A. Lehman Employee of: Janssen, B. Osborne Employee of: Janssen, K. Maslova Employee of: Janssen, C. Tkaczyk Employee of: Janssen
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
希望天下0贩的0应助angela采纳,获得10
1秒前
1秒前
1秒前
安全123完成签到,获得积分20
3秒前
李嘉图的栗子完成签到,获得积分10
4秒前
Orange应助科研通管家采纳,获得10
4秒前
地表飞猪应助科研通管家采纳,获得10
4秒前
我是老大应助科研通管家采纳,获得10
4秒前
彭于晏应助chen采纳,获得10
4秒前
领导范儿应助科研通管家采纳,获得10
4秒前
汉堡包应助科研通管家采纳,获得10
4秒前
科研通AI2S应助科研通管家采纳,获得10
4秒前
斯文败类应助科研通管家采纳,获得10
4秒前
CipherSage应助科研通管家采纳,获得10
4秒前
隐形曼青应助科研通管家采纳,获得10
4秒前
SYLH应助科研通管家采纳,获得20
5秒前
5秒前
赘婿应助科研通管家采纳,获得10
5秒前
Owen应助科研通管家采纳,获得10
5秒前
田様应助科研通管家采纳,获得30
5秒前
JamesPei应助科研通管家采纳,获得10
5秒前
5秒前
所所应助科研通管家采纳,获得10
5秒前
昏睡的蟠桃应助科研通管家采纳,获得200
5秒前
搜集达人应助科研通管家采纳,获得10
5秒前
ding应助科研通管家采纳,获得10
5秒前
Jasper应助科研通管家采纳,获得10
6秒前
在水一方应助科研通管家采纳,获得10
6秒前
6秒前
Ava应助科研通管家采纳,获得10
6秒前
6秒前
6秒前
6秒前
6秒前
6秒前
6秒前
7秒前
7秒前
如云发布了新的文献求助10
8秒前
angela给angela的求助进行了留言
8秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
Research on Disturbance Rejection Control Algorithm for Aerial Operation Robots 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038657
求助须知:如何正确求助?哪些是违规求助? 3576306
关于积分的说明 11375198
捐赠科研通 3306108
什么是DOI,文献DOI怎么找? 1819379
邀请新用户注册赠送积分活动 892698
科研通“疑难数据库(出版商)”最低求助积分说明 815066